FATE Fate Therapeutics Inc

USD 1.28 -0.07 ( -5.19%)
Icon

Fate Therapeutics Inc (FATE) Stock Analyst Ratings & Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.28

-0.07 (-5.19%)

USD 0.10B

1.24M

USD 4.40(+243.75%)

USD 14.50 (+1032.81%)

Icon

FATE

Fate Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.28
-0.07 ( -5.19%)

Fate Therapeutics Inc (FATE) Stock Forecast

Show ratings and price targets of :
USD 4.40
(+243.75%)

Based on the Fate Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for Fate Therapeutics Inc is USD 4.40 over the next 12 months. Fate Therapeutics Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Fate Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Fate Therapeutics Inc’s stock price was USD 1.28. Fate Therapeutics Inc’s stock price has changed by +15.32% over the past week, +41.80% over the past month and -66.93% over the last year.

Analyst Ratings

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...